LTFS
RDY icon

Ladenburg Thalmann Financial Services’s Dr. Reddy's Laboratories RDY Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$6K Sell
755
-840
-53% -$6.63K ﹤0.01% 4714
2019
Q3 		$12K Buy
1,595
+1,590
+31,800% +$11.8K ﹤0.01% 4312
2019
Q2 		$0 Buy
+5
New +$39 ﹤0.01% 5378
2018
Q4 		– Sell
-1,000
Closed -$7K – 5305
2018
Q3 		$7K Hold
1,000
– – ﹤0.01% 4454
2018
Q2 		$7K Hold
1,000
– – ﹤0.01% 4448
2018
Q1 		$7K Hold
1,000
– – ﹤0.01% 4448
2017
Q4 		$8K Sell
1,000
-1,000
-50% -$7.2K ﹤0.01% 4314
2017
Q3 		$14K Buy
2,000
+1,000
+100% +$7.19K ﹤0.01% 3897
2017
Q2 		$8K Hold
1,000
– – ﹤0.01% 4140
2017
Q1 		$8K Sell
1,000
-125
-11% -$1.08K ﹤0.01% 4113
2016
Q4 		$10K Sell
1,125
-60
-5% -$558 ﹤0.01% 3899
2016
Q3 		$11K Sell
1,185
-110
-8% -$1.05K ﹤0.01% 3767
2016
Q2 		$13K Sell
1,295
-225
-15% -$2.06K ﹤0.01% 3616
2016
Q1 		$14K Buy
1,520
+135
+10% +$1.21K ﹤0.01% 3502
2015
Q4 		$13K Sell
1,385
-2,130
-61% -$23.3K ﹤0.01% 3525
2015
Q3 		$45K Buy
3,515
+80
+2% +$994 ﹤0.01% 2545
2015
Q2 		$38K Buy
3,435
+475
+16% +$5.24K ﹤0.01% 2781
2015
Q1 		$33K Buy
2,960
+245
+9% +$2.6K ﹤0.01% 2873
2014
Q4 		$27K Buy
2,715
+1,280
+89% +$13.5K ﹤0.01% 2793
2014
Q3 		$15K Hold
1,435
– – ﹤0.01% 2856
2014
Q2 		$12K Hold
1,435
– – ﹤0.01% 2983
2014
Q1 		$13K Hold
1,435
– – ﹤0.01% 2819
2013
Q4 		$12K Sell
1,435
-4,700
-77% -$37.2K ﹤0.01% 2837
2013
Q3 		$46K Buy
6,135
+805
+15% +$5.86K ﹤0.01% 1879
2013
Q2 		$40K Buy
+5,330
New +$38.9K ﹤0.01% 1876

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AG
Aperio Group Sausalito, California $33.8B AUM 31.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Ladenburg Thalmann Financial Services's RDY Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its Dr. Reddy's Laboratories (RDY) stake by 53% in Q4 2019, selling an estimated $6.63K and leaving 755 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #4714.

Ladenburg Thalmann Financial Services first reported a position in RDY in Q2 2013 and has held it in 25 quarters since. The position peaked at $46K in Q3 2013. 148 funds tracked by Wall St. Rank hold RDY as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 755 shares of Dr. Reddy's Laboratories worth $6K as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 840 Dr. Reddy's Laboratories shares in Q4 2019, an estimated $6.63K.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4714 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Dr. Reddy's Laboratories in Q2 2013 and has held it in 25 quarters since.
  • Ladenburg Thalmann Financial Services's Dr. Reddy's Laboratories position peaked at $46K in Q3 2013.
  • 148 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.